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Background
The potential for unintended consequences of the
spread of foreign genes (either via vertical or horizontal
transfer) and of pleiotropic effects following transgene
expression may be enhanced in long-lived forest trees.
The COST Action FP0905 will focus on four key aspects
related to the biosafety of genetically modified trees
(GMTs): (a) analyses of the efficiency of existing gene
containment strategies to avoid or if not possible to
minimize gene flow; (b) facilitate efforts to develop site-
specific integration of transgenes in tree genomes to
minimize variability of transgene expression and pleio-
tropic effects, (c) evaluate possible methods to monitor
GMTs in the whole production chain, and (d) conduct
socio-economic and cost/benefit analyses in relation to
the use of GMTs in plantations.
This Action combines multidisciplinary knowledge
generated with transgenic lines of different forest genera
(such as, Populus spp., Pinus spp., Eucalyptus spp.,
Betula spp., Castanea spp., Picea spp., etc.) as well as
extensive expertise in correlated topics. The information
gained should contribute to strengthen the scientific
basis for the execution of the EU policy directives
related to transgenic trees intended for cultivation in
Europe. The main objective of the COST Action is to
evaluate and substantiate the scientific knowledge rele-
vant for GMT biosafety protocols by putting together
already existing information generated in various Eur-
opean and Non-EU countries as basis for future EU
policy and regulation for the environmental impact
assessment and the safe development and practical use
of GMTs.
Work plan and organisation
To reach its aim, the work plan of the Action is orga-
nised in 4 Working Groups (WGs) to implement colla-
boration of scientists.
WG 1 - Biological characterization of GMTs: to charac-
terize the GMTs in respect to their genetic and phenoty-
pic features relevant for gene flow, gene containment and
gene targeting.
WG 2 - Environmental impact assessment and moni-
toring of GMTs in the whole production chain from
plantation to final products: to study environmental risk
assessment strategies and monitoring the GMTs along
the whole production chain.
WG 3 - Socio-economic implications of and recom-
mendations for the use of GMTs: to make socio-eco-
nomics analyses of the use of GMTs considering the
concerns and acceptance by the public, the economic
potential for GMTs and R&D efforts to be invested, as
well as cost/benefit analyses, and propose recommenda-
tions for the use of GMTs.
WG 4 - Management of intranet - internet websites
and dissemination: through a website (www.cost-action-
fp0905.eu), provide science-based information and
increase public awareness in the utilization of GMTs in
forest plantation and at the same time safeguarding the
environment
The knowledge gained will be summarised in a book
as a final output of this Action which will report the
state of art of knowledge and research on GMTs with
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suggestion on how to effectively implement present EU
directives on GMO considering the problematic of for-
est trees and their environmental impacts.
The Action started the 12th of April 2010 and it will
end the 11th of April 2014. Actually, 23 COST countries
(Austria, Belgium, Bosnia and Herzegovina, Bulgaria,
Croatia, Denmark, Estonia, Finland, France, Germany,
Greece, Israel, Italy, Latvia, Netherlands, Norway, Roma-
nia, Serbia, Slovak Republic, Slovenia, Spain, Sweden,
and United Kingdom) have signed the Memorandum of
Understanding (MoU). Seven NON-COST countries
(Albania, Australia, Canada, China, New Zealand, South
Africa, USA) are participating to the Action.
Conclusion
With integration of all the countries listed above, the
EU COST Action FP0905 is expected to generate
important benefits as it also foresees a strong collabora-
tion among R&D bodies and legislative directives. This
kind of collaboration will be fundamental, on the one
hand, to address policy-making efforts and, on the other
hand, to allow the scientific community to discuss to
public concerns in a responsible way, particularly con-
cerning socio-economic implications and biosafety issues
of transgenic tree plantations.
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